[Featured Stock] Coreana Rises as Patent on Violet Composition Highlights Discovery of Hair Loss Treatment Ingredient from Kongjebikkot

[Asia Economy Reporter Minwoo Lee] Koreana's stock price is on the rise. Investor sentiment appears to have been driven by news that a patent related to Viola composition exists, following research results revealing hair loss treatment components in Kongjebikkot.

As of 10:37 AM on the 16th, Koreana's stock price recorded 5,680 KRW, up 9.85% from the previous day. The news that hair loss treatment components were discovered in Kongjebikkot seems to have acted as a positive factor.

The National Nakdong River Biological Resources Center under the Ministry of Environment announced on the 15th that, through joint research with Jeju National University, it confirmed that Kongjebikkot extract is effective in promoting hair growth and inhibiting hair loss, and has filed a related patent. After extracting dermal papilla cells, which are cells that promote hair growth, from laboratory mice, Kongjebikkot extract was injected, revealing that this extract is effective in inhibiting hair loss. Kongjebikkot, belonging to the Viola family, is a perennial plant that grows in moist mountain and field areas and is native throughout the country, including Gyeonggi-do, Gangwon-do, and Jeju-do.

Previously, Koreana acquired a cosmetic composition containing ribonucleic acid and Viola extract on November 6, 2017. It is explained that formulations containing Viola extract enhance the stability of micro ribonucleic acid, which has excellent anti-aging and whitening activities, thereby maximizing the effects of micro ribonucleic acid.

This content was produced with the assistance of AI translation services.